Access to hematopoietic stem cell transplant for patients with sickle cell anemia.
Pediatr Blood Cancer
; 65(9): e27105, 2018 09.
Article
em En
| MEDLINE
| ID: mdl-29693782
ABSTRACT
Hematopoietic stem cell transplantation (HSCT) is a curative therapy for patients with phenotypically severe sickle cell anemia, and survival rates following matched-sibling HSCT are very high. However, despite cure rates much higher than HSCT for malignant diseases, the field has been slow to adopt this treatment modality for sickle cell anemia. This article explores some of the social forces that may contribute to this dichotomy.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Estudantes de Medicina
/
Transplante de Células-Tronco Hematopoéticas
/
Diversidade Cultural
/
Disparidades em Assistência à Saúde
/
Acessibilidade aos Serviços de Saúde
/
Anemia Falciforme
Limite:
Female
/
Humans
/
Male
Idioma:
En
Ano de publicação:
2018
Tipo de documento:
Article